Accueil>>Lipids>> Sphingolipids>>Sphinganine-1-phosphate (d18:0)

Sphinganine-1-phosphate (d18:0) (Synonyms: C18-dihydro Sphingosine-1-phosphate, D-erythro-Sphinganine-1-phosphate, dihydro-D-erythro-Sphingosine-1-phosphate)

Catalog No.GC44927

La sphinganine-1-phosphate (d18:0) (D-érythro-dihydrosphingosine 1-phosphate) est un métabolite sphingolipidique polaire qui régule la migration cellulaire, la différenciation, la survie et les processus physiologiques complexes.

Products are for research use only. Not for human use. We do not sell to patients.

Sphinganine-1-phosphate (d18:0) Chemical Structure

Cas No.: 19794-97-9

Taille Prix Stock Qté
500μg
83,00 $US
En stock
1mg
150,00 $US
En stock
5mg
588,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Sphinganine-1-phosphate is an intermediate in the metabolism of glycosphingolipids and sphingolipids. It acts as an antagonist at the sphingosine-1-phosphate (S1P1/EDG-1) receptor (Ki = 15 nM). Sphinganine-1-phosphate prevents liver and kidney damage following hepatic ischemia and reperfusion injury in mice at doses lower than 0.1 and 0.2 mg/kg when administered prior to or following reperfusion, respectively. It has antifibrotic effects in scleroderma fibroblasts through normalization of PTEN protein levels, collagen and matrix metalloproteinase-1 (MMP-1) expression, and Smad3 phosphorylation.

Avis

Review for Sphinganine-1-phosphate (d18:0)

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sphinganine-1-phosphate (d18:0)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.